Designed to radically simplify the process of clinical translation for Regenerative Medicine companies that utilize hMSCs within their manufacturing process.
(PRWeb November 12, 2018)
Read the full story at https://www.prweb.com/releases/roosterbio_submits_u_s_fda_master_files_for_clinicontrol_line_of_human_mesenchymal_stem_stromal_cell_products/prweb15909351.htm
For more information, please visit
https://www.prweb.com/releases/roosterbi[...]ell_products/prweb15909351.htm